Search

Your search keyword '"Mootien, Joy"' showing total 42 results

Search Constraints

Start Over You searched for: Author "Mootien, Joy" Remove constraint Author: "Mootien, Joy"
42 results on '"Mootien, Joy"'

Search Results

2. Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

3. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

4. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

6. 2748. Ceftolozane/tazobactam For the Treatment of Cystic Fibrosis Patients: Results from a French Prospective Cohort Study

8. Ceftolozane/Tazobactam for the Treatment of Complicated Infections in Hospital Settings—A French Real-world Study.

9. Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

10. Additional file 1 of Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

11. Relationship between serotypes, disease characteristics and 30-day mortality in adults with invasive pneumococcal disease

12. Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome Associated with COVID-19: An Emulated Target Trial Analysis

13. Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19

14. Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial

15. Characteristics and prognosis of bloodstream infection in patients with COVID-19 admitted in the ICU: an ancillary study of the COVID-ICU study

16. Benefits and risks of noninvasive oxygenation strategy in COVID-19: a multicenter, prospective cohort study (COVID-ICU) in 137 hospitals

17. An open-label randomized, controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19 – Final results from the DisCoVeRy trial

18. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

19. Efficacy and Safety of Baricitinib for the Treatment of Hospitalized Adults with Severe or Critical COVID-19 (Bari-SolidAct): A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Trial

20. Predicting 90-day survival of patients with COVID-19: Survival of Severely Ill COVID (SOSIC) scores

22. Characterization of pulmonary impairment associated with COVID-19 in patients requiring mechanical ventilation

23. Clinical characteristics and risk factors associated with severe COVID-19: prospective analysis of 1,045 hospitalised cases in North-Eastern France, March 2020

24. The BAS2IC Score: A Useful Tool to Identify Patients at High Risk of Early Progression to Severe Coronavirus Disease 2019

25. Antiviral drugs in hospitalized patients with COVID-19 - the DisCoVeRy trial

26. Remdesivir for the Treatment of Hospitalised Patients with COVID-19 (DisCoVeRy): A Randomised, Controlled, Open-Label Trial

27. Characteristics of Critically Ill Patients with Covid-19: A Cohort Study in Medical Intensive Care Unit (Mulhouse, France)

30. Risk Factors Associated with Severe COVID-19 in Eastern France: Analysis of 1045 Cases

31. Macrophage Activation in COVID-19 Patients in Intensive Care Unit

32. Factors Associated With Severe Nonmeningitis Invasive Pneumococcal Disease in Adults in France

33. Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19

34. French Intensive Care Society, International congress – Réanimation 2016

35. A prospective, observational study of fidaxomicin use for Clostridioides difficile infection in France.

36. Traduction sémantique en français et implémentation du Nursing Activities Score en Belgique

37. Anasarca, Fever, Thrombocytopenia, Organomegaly, and Multiorgan Failure in a 24-Year-Old Pregnant Woman

38. The BAS2IC Score: A Useful Tool to Identify Patients at High Risk of Early Progression to Severe Coronavirus Disease 2019.

39. Clinical usefulness of 18 F–FDG PET/CT for initial staging and assessment of treatment efficacy in patients with lymph node tuberculosis

40. A prospective, observational study of fidaxomicin use for Clostridioides difficileinfection in France

41. Characterization of pulmonary impairment associated with COVID-19 in patients requiring mechanical ventilation.

42. The BAS 2 IC Score: A Useful Tool to Identify Patients at High Risk of Early Progression to Severe Coronavirus Disease 2019.

Catalog

Books, media, physical & digital resources